BioCryst Pharmaceuticals
BCRX
BCRX
236 hedge funds and large institutions have $1.23B invested in BioCryst Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 99 increasing their positions, 57 reducing their positions, and 30 closing their positions.
Holders
236
Holders Change
-5
Holders Change %
-2.07%
% of All Funds
3.72%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.09%
New
26
Increased
99
Reduced
57
Closed
30
Calls
$18.3M
Puts
$4.82M
Net Calls
+$13.5M
Net Calls Change
-$2.37M
